Michael J. LaBarre
2020
Compensation breakdown
Non-Equity Incentive Plan | $220,163 |
---|---|
Option Awards | $650,007 |
Salary | $475,000 |
Stock Awards | $650,009 |
Other | $15,018 |
Total | $2,010,197 |
LaBarre received $650K in stock awards, accounting for 32% of the total pay in 2020.
LaBarre also received $220.2K in non-equity incentive plan, $650K in option awards, $475K in salary and $15K in other compensation.
Rankings
In 2020, Michael J. LaBarre's compensation ranked 5,486th out of 13,090 executives tracked by ExecPay. In other words, LaBarre earned more than 58.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,486 | 58th |
Manufacturing | 2,257 | 60th |
Chemicals And Allied Products | 900 | 60th |
Drugs | 777 | 60th |
Biological Products, Except Diagnostic Substances | 186 | 55th |
Pay ratio
Michael J. LaBarre's Pay | $2,010,197 |
---|---|
Median Employee's Pay | $223,441 |
Pay Ratio | 9to 1 |
In 2020, the annual total compensation of Michael J. LaBarre was $2,010,197.
The annual total compensation of the median employee at Halozyme Therapeutics was $223,441.
The ratio of Michael J. LaBarre's pay to the pay of median employee was therefore 9 to one.
LaBarre's colleagues
We found four more compensation records of executives who worked with Michael J. LaBarre at Halozyme Therapeutics in 2020.